These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7605510)

  • 1. Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis.
    Taliani G; Duca F; Lecce R; Livoli D; Pasquazzi C; De Bac C
    Hepatology; 1995 Jun; 21(6):1760-1. PubMed ID: 7605510
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative liver testing with MEG-X: more optimism?
    Ziebell J; Shaw-Stiffel TA
    Hepatology; 1995 Jun; 21(6):1762-4. PubMed ID: 7768526
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatic lidocaine metabolism and liver histology.
    Fabbri A; Bianchi GP; Marchesini G
    Hepatology; 1995 Jun; 21(6):1761-2. PubMed ID: 7768525
    [No Abstract]   [Full Text] [Related]  

  • 4. Omeprazole decreased formation of monoethylglycinexylidide in a patient with chronic active hepatitis.
    Campo N; Alvarez S; Borzone S; Caglieris S; Zentilin P; Testa R
    Am J Gastroenterol; 1994 Aug; 89(8):1271-2. PubMed ID: 8053457
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis.
    Shiffman ML; Luketic VA; Sanyal AJ; Duckworth PF; Purdum PP; Contos MJ; Mills AS; Edinboro LE; Poklis A
    Hepatology; 1994 Apr; 19(4):933-40. PubMed ID: 8138268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: hepatitis C virus-associated steatosis--pathogenic mechanisms and clinical implications.
    Adinolfi LE; Durante-Mangoni E; Zampino R; Ruggiero G
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():52-5. PubMed ID: 16225474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic lidocaine metabolism is useful in the selection of patients in need of liver transplantation.
    Luketic VA; Shiffman ML; Fisher RA; Sanyal AJ; Purdum PP; Posner MP
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1072-4. PubMed ID: 8442046
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C and hepatic steatosis.
    Patel JH; Cobbold JF; Thomas HC; Taylor-Robinson SD
    QJM; 2010 May; 103(5):293-303. PubMed ID: 20139103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic steatosis correlates with the postoperative recurrence of hepatitis C virus-associated hepatocellular carcinoma.
    Takuma Y; Nouso K; Makino Y; Saito S; Takayama H; Takahara M; Takahashi H; Murakami I; Takeuchi H
    Liver Int; 2007 Jun; 27(5):620-6. PubMed ID: 17498246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver steatosis associated with chronic hepatitis C.
    Irimia E; Mogoantă L; Predescu IO; Efrem IC; Stănescu C; Streba LA; Georgescu AM
    Rom J Morphol Embryol; 2014; 55(2):351-6. PubMed ID: 24969985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications.
    Sanyal AJ
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():48-51. PubMed ID: 16225473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S; Younossi ZM
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis.
    Wang CC; Hsu CS; Liu CJ; Kao JH; Chen DS
    J Gastroenterol Hepatol; 2008 May; 23(5):779-82. PubMed ID: 18028349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: nonalcoholic fatty liver disease and hepatitis C virus--partners in crime.
    Blonsky JJ; Harrison SA
    Aliment Pharmacol Ther; 2008 May; 27(10):855-65. PubMed ID: 18315584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.
    Fartoux L; Chazouillères O; Wendum D; Poupon R; Serfaty L
    Hepatology; 2005 Jan; 41(1):82-7. PubMed ID: 15690484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiologies of liver cirrhosis and their relationships with glucose metabolism disorders in Shanghai].
    Xu ZJ; Zhong Y; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):470-1. PubMed ID: 19567033
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired hepatic metabolism of i.v. lignocaine as an index of cellular damage from carbon monoxide poisoning.
    Scott CB; Henderson A; Potter JM; Hickman PE; Walker NI; Balderson G; Lynch SV; Strong RW
    Med J Aust; 1992 Mar; 156(5):367. PubMed ID: 1588887
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatic steatosis associated with hepatitis C virus infection.
    Cornianu M; Dema A; Tăban S; Lazăr D; Lazăr E; Costi S
    Rom J Morphol Embryol; 2005; 46(4):283-9. PubMed ID: 16688364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
    Mihm S
    Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.